Drawing for ALINITY

USPTO serial 86505094

ALINITY

Reviewed by CopyMark Law Group

Reg. 5607328Status 702Registered
Filing date
Status date
Registration date
Nov 13, 2018
Examiner
MEYERS, MORGAN LAURA
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ALINITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan Heinz

Jordan Heinz ABBOTT LABORATORIES100 Abbott Park RoadABBOTT PARK, IL 60064United States

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and software for use in the field of medical diagnostics; computer software and hardware for medical diagnostic instruments; computer software and hardware supporting medical diagnostic instruments; computer software and hardware for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers, blood screening instruments, and instruments for blood, bodily fluid and tissue testing; computer software and hardware for configuring medical diagnostic instruments; computer software and hardware supporting hematology analyzers, clinical chemistry analyzers, immunoassay analyzers, blood screening instruments, and instruments for blood, bodily fluid and tissue testing; computer software and hardware for configuring medical diagnostic instruments; computer software and hardware for configuring hematology analyzers, clinical chemistry analyzers, immunoassay analyzers, blood screening instruments, and blood, bodily fluid and tissue testing systems; computer software and hardware for monitoring medical diagnostic instruments; computer software and hardware for monitoring hematology analyzers, clinical chemistry analyzers, immunoassay analyzers, blood screening instruments, and blood, bodily fluid and tissue testing systems; electronic data interfacing for medical diagnostic instruments; electronic data interfacing for hematology analyzers, clinical chemistry analyzers, immunoassay analyzers, blood screening instruments, and blood, bodily fluid and tissue testing systems; computer software and hardware for managing interface between medical diagnostic instruments; computer software and hardware for managing interface between laboratory instruments; computer software and hardware for troubleshooting regarding medical diagnostic instruments; computer software and hardware for troubleshooting regarding laboratory instruments; computer software and hardware for processing diagnostic medical testing data; computer software and hardware for processing diagnostic laboratory data; computer software and hardware for use in medical diagnostic testing; computer software and hardware for identification and analysis of nucleic acid sequences, nucleic acids for pathogen identity, drug resistance characteristics and forensic profiles; computer software for front-end processing, instrument control, data analysis and reporting for molecular diagnostic instruments; electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems recorded on computer media, and related softwareACTIVEMar 31, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 7, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 7, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 5, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Nov 13, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 27, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 10, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 9, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 11, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 9, 2018IUAFUSE AMENDMENT FILED—
Jul 9, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 9, 2018DOCKASSIGNED TO EXAMINER—
Jan 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 16, 2018EX5GSOU EXTENSION 5 GRANTED—
Jan 16, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 12, 2018EXT5SOU EXTENSION 5 FILED—
Jan 12, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 6, 2017EX4GSOU EXTENSION 4 GRANTED—
Jul 6, 2017EXT4SOU EXTENSION 4 FILED—
Jul 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 11, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 9, 2017EX3GSOU EXTENSION 3 GRANTED—
Jan 9, 2017EXT3SOU EXTENSION 3 FILED—
Jan 9, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 16, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 14, 2016EX2GSOU EXTENSION 2 GRANTED—
Aug 12, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 13, 2016EXT2SOU EXTENSION 2 FILED—
Jul 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 15, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 13, 2016EX1GSOU EXTENSION 1 GRANTED—
Jan 13, 2016EXT1SOU EXTENSION 1 FILED—
Jan 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 14, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 13, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 13, 2015ALIEASSIGNED TO LIE—
Mar 23, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Mar 18, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 18, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 18, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 11, 2015DOCKASSIGNED TO EXAMINER—
Jan 28, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 19, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance